A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: Improving clinical outcomes (Retraction in: Anesthesia and Analgesia (2009) 108:4 (1350))

Anesthesia and Analgesia

Volumn 106, Issue 4, 2008, Pages 1258-1264

  Reuben, Scott S ^a,c   Buvenandran, Asokumar ^b   Katz, Brennan ^a   Kroin, Jeffrey S ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; DIPHENHYDRAMINE; FENTANYL; HYDROCODONE; METOCLOPRAMIDE; MORPHINE; NALBUPHINE; ONDANSETRON; OXYCODONE; PARACETAMOL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPIDURAL ANESTHESIA; FEMALE; FOLLOW UP; HUMAN; KNEE FUNCTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; TOTAL KNEE REPLACEMENT; UNSPECIFIED SIDE EFFECT; VOMITING;

AGED; ANALGESIA, PATIENT-CONTROLLED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; MOTOR ACTIVITY; PAIN MEASUREMENT; PLACEBOS; PYRAZOLES; RANGE OF MOTION, ARTICULAR; SULFONAMIDES; TREATMENT OUTCOME;

EID: 41349102031     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318165e208     Document Type: Article

References (29)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007;89:780-5
2. Meding JB, Keating EM, Ritter MA, Faris PM. Total knee arthroplasty after high tibial oseotomy: a comparison study in patients who had bilateral total knee replacement. J Bone Joint Surg Am 2000;82:1252-7
3. Zavadak KH, Gibson KR, Whitley DM, Britz P, Kwoh CK. Variability in the attainment of functional milestones during the acute care admission after total joint replacement. J Rheumatol 1995;22:482-7
4. Brander VA, Stulberg SD, Adams AD, Harden RN, Bruehl S, Stanos SP, Houle T. Predicting total knee replacement pain. A prospective, observational study. Clin Orthop 2003;416:27-36
5. United States Acute Pain Management Guideline Panel. Acute Pain Management: Operative or Medical Procedures and Trauma. Pub. No. 92-0032. Rockville, Maryland: United States Department of Health and Human Services, Public Health Service Agency for Health Care Policy and Research, 1992
6. Reuben SS, Sklar J. Postoperative pain management for outpatient arthroscopic knee surgery. Current concepts review. J Bone Joint Surg 2000;82:1754-66
7. Reuben SS, Buvanendran A. Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques. Current concepts Review. J Bone Joint Surg Am 2007;89:1343-58
8. Connelly CS, Panush RS. Should nonsteroidal anti-inflammatory drugs be stopped before elective surgery? Arch Intern Med 1991;151:1963
9. Robinson CM, Christie J, Malcolm-Smith N. Nonsteroidal anti-inflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 1993;8:607
10. Slappendel R, Weber EWG, Bugter MLT, Dirksen R. The intensity of preoperative pain is directly correlated with the amount of morphine needed for postoperative analgesia. Anesth Analg 1998;88:146-8
11. Reuben SS, Fingeroth R, Krushell R, Maciolek H. Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty 2002;17:26-31
12. Buvenandran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, Rosenberg AG. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement. JAMA 2003;290:2411-8
13. Mallory TH, Lombardi AV, Fada RA, Dodds KL, Adams JB. Pain management for joint arthroplasty. Preemptive analgesia. J Arthroplasty 2002;17:131-6
14. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 1989;248:13-4
15. Chiu KY, Tang WM, Yau WP. Knee flexion after total knee arthroplasty. J Orthop Surg (Hong Kong) 2002;10:194-202
16. Colwell CW Jr, Morris BA. The influence of continuous passive motion on the results of total knee arthroplasty. Clin Orthop 1992;276:225-8
17. Laubenthal KN, Smidt GL, Kettelkamp DB. A quantitative analysis of knee motion during activities of daily living. Phys Ther 1972;52:34-43
18. Jevsevar DS, Riley PO, Hodge WA, Krebs DE. Knee kinematics and kinetics during locomotor activities of daily living in subjects with knee arthroplasty and in healthy control subjects. Phys Ther 1993;73:229-39
19. Capdevila X, Barthelet Y, Biboulet P, Ryckwaert Y, Rubenovitch J, d'Athis F. Effect of perioperative analgesic technique on the surgical outcome and duration of rehabilitation after major knee surgery. Anesthesiology 1999;91:8-15
20. Wang H, Boctor B, Verner J. The effect of single-injection femoral nerve block on rehabilitation and length of hospital stay after total knee replacement. Reg Anesth Pain Med 2002;27:139-44
21. Buvanendran A, Kroin JS, Berger RA, Kroin JS, Berger RA, Hallab NJ, Saha C, Negrescu C, Moric M, Caicedo MS, Tuman KJ. Upregulation of prostaglandin E2 and interleukins in the central nervous system and peripheral tissue during and after surgery in humans. Anesthesiology 2006;104:403-10
22. Worland RL, Arredondo J, Angles F, Lopez-Jimenez F, Jessup DE. Home continuous passive motion machine versus professional physical therapy following total knee replacement. J Arthroplasty 1998;13:784-87
23. Reuben SS, Buvanendran A, Kroin JS Raghunathan K. The analgesic efficacy of celecoxib, pregabalin and their combination for spinal fusion surgery. Anesth Analg 2006;103:1271-7
24. White PF, Sacan O, Tufanogullari B, Engl M, Nuangchamnong N, Ogunnaike B. Effect of short term postoperative celecoxib administration on patient outcome after outpatient laparoscopic surgery. Can J Anaesth 2007;54:342-8
25. Borgeat A, Ekatodramis G, Schenker CA. Postoperative nausea and vomiting in regional anesthesia. Anesthesiology 2003;98:530-47
26. Girod V, Bouvier M, Grelot L. Characterization of lipopolysaccharide- induced emesis in conscious piglets: effects of cervical vagotomy, cyclooxygenase inhibitors and 5-HT(3) receptor antagonism. Neuropharmacology 2000;39:2329-35
27. Reuben SS, Ekman EF, Charron D. Evaluating the analgesic efficacy of administering celecoxib as a component of multimodal analgesia for outpatient anterior cruciate ligament reconstruction surgery. Anesth Analg 2007;105:222-7
28. Reuben SS, Ekman EF. The effect of initiating a preventive multimodal analgesic regimen upon long-term patient outcomes for outpatient anterior cruciate ligament reconstruction surgery. Anesth Analg 2007;105:228-32
29. Samana CM, Bastein O, Forestier F, Denninger MH, Isetta C, Juliard JM, Lasne D, Leys D, Mismetti P. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - Summary Statement. Can J Anaesth 2002;49:S26-35